Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
British Journal of Pharmacology|March 28, 2025
Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activatorShuaishuai Gong, Hong Chen, Shuhua Fang, et al.
European Journal of Medicinal Chemistry|March 4, 2022
Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluationXi Xu, Di Zhang, Tengteng Zhao, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 8, 2025
Silibinin alleviates acute liver failure by modulating AKT/GSK3β/Nrf2/GPX4 pathwayYue Li, Hailan Li, Minhui Sun, et al.
Pharmacological Research|August 10, 2014
Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1Yan Sun, Jia Li, Na Xiao, et al.
International Journal of Molecular Sciences|August 26, 2017
Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca2+-Calcineurin-Mediated Drp1 Signaling PathwaysYe Yang, Yushan Tian, Siyao Hu, et al.
British Journal of Pharmacology|April 1, 2026
Astragaloside II alleviates cardiac hypertrophy by targeting aminoacylase-1: a novel mechanism via the β-catenin/transcription factor 4/ubiquitin C-terminal hydrolase L1 axisYangyang Lin, Shuaishuai Gong, Qiong Lai, et al.
Chinese Journal of Natural Medicines|April 30, 2026
Silibinin meglumine ameliorates hepatic encephalopathy via inhibiting UCP2-mediated oxidative stress and mitochondrial dysfunctionYue Li, Hong Chen, Xinyi Chen, et al.
British Journal of Pharmacology|November 23, 2025
6‴-Feruloylspinosin ameliorates pressure overload-induced heart failure with comorbid insomnia through the activation of RORαYan Yan, Shuaishuai Gong, Minhui Sun, et al.
Oncotarget|April 7, 2016
Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancerBihui Huang, Mingzhu Yin, Xia Li, et al.
Toxicology and Applied Pharmacology|June 18, 2022
The myosin II inhibitor, blebbistatin, ameliorates pulmonary endothelial barrier dysfunction in acute lung injury induced by LPS via NMMHC IIA/Wnt5a/β-catenin pathwayJiazhi Zhang, Ziqian Pan, Jianhao Zhou, et al.
Pageof 13